Trial NCT00353457

View at ClinicalTrials.gov 
Org. Study IDs: 803437
Secondary IDs: UPCC 09204

Last trial update was posted on 2020-04-09

MeSH Interventions

Capecitabine Cetuximab Oxaliplatin

MeSH Conditions

Adenocarcinoma Rectal Neoplasms

Other Conditions

Rectal Cancer

Stopping Reasons

new studies were finding that Erbitux was not beneficial

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID